Eagle Pharmaceuticals, Inc. Debt Conversion, Converted Instrument, Amount
Eagle Pharmaceuticals, Inc. reported Debt Conversion, Converted Instrument, Amount of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2016-02-29
- Eagle Pharmaceuticals, Inc. debt conversion, converted instrument, amount for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- Eagle Pharmaceuticals, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- Eagle Pharmaceuticals, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-09-30 was $0.00.
- Eagle Pharmaceuticals, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-06-30 was $0.00.
- Eagle Pharmaceuticals, Inc. debt conversion, converted instrument, amount for fiscal 2015 was $0.00.
- Eagle Pharmaceuticals, Inc. debt conversion, converted instrument, amount for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- Eagle Pharmaceuticals, Inc. debt conversion, converted instrument, amount for fiscal 2013 was $10.06M.
- Eagle Pharmaceuticals, Inc. debt conversion, converted instrument, amount for fiscal 2012 was $0.00.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-29 | |||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-15 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $414.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $414.00K derived: sum of 3 quarters · filed 2016-02-29 | $0.00 10-K · filed 2016-02-29 |
| 2014-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-11 | $414.00K derived: sum of 2 quarters · filed 2015-05-15 | $0.00 10-Q · filed 2014-08-11 | $546.70K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $414.00K 10-Q · filed 2015-05-15 | $0.00 10-Q · filed 2014-05-15 | $546.70K derived: sum of 3 quarters · filed 2016-02-29 | $546.70K derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $133.00K 10-QT · filed 2015-02-17 | $132.70K derived: sum of 2 quarters · filed 2016-02-29 | $132.70K derived: sum of 3 quarters · filed 2016-02-29 | |
| 2013-09-30 | -$296.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$296.00 derived: sum of 2 quarters · filed 2016-02-29 | $10.06M 10-K · filed 2016-02-29 | |
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-11 | $10.06M 10-Q · filed 2014-08-11 | ||
| 2013-03-31 | $10.06M 10-Q · filed 2014-05-15 | |||
| 2012-09-30 | $0.00 10-K · filed 2014-12-22 |